The aim of this study was to assess the shear bond strength (SBS) of zirconia ceramic to composite resin with various surface treatments following pressure changes. Totally, 135 zirconia blocks were prepared by computer-aided design/computer-aided manufacturing technology. The samples were divided into 9 groups (n=15). Three surface treatments including sandblasting, tribo-chemical preparation, and laser application were used. For each method, 45 samples were considered and tested under different pressure conditions. Z-Prime Plus primer was used for bonding of all samples to composite cylinders. All specimens were stored in water for 24 h, underwent thermocycling, and were then placed in a pressure chamber under normal-, high-, and low-pressure conditions. Then, the SBS test was performed for each sample. Data were analyzed by two-way and one-way ANOVA (α=0.05). The SBS was significantly higher in sandblasting and tribochemical preparation compared with laser irradiation (P<0.05). There was no statistically significant difference in SBS of sandblasting and tribochemical preparation methods (P>0.05). Sandblasting, tribochemical preparation, and laser methods did not show a significant difference in SBS at different pressures (P>0.05). Sandblasting and tribochemical preparation yielded a higher SBS than laser. Different pressures had no effect on SBS, irrespective of surface preparation method.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355849PMC
http://dx.doi.org/10.18502/fid.v18i26.6936DOI Listing

Publication Analysis

Top Keywords

surface treatments
12
sandblasting tribochemical
12
tribochemical preparation
12
treatments pressure
8
pressure conditions
8
shear bond
8
bond strength
8
zirconia ceramic
8
ceramic composite
8
composite resin
8

Similar Publications

Bacterial keratitis (BK) is a type of corneal inflammation resulting from bacterial infection in the eye. Although nanozymes have been explored as promising materials in corneal wound healing, currently available nanozymes lack sufficient catalytic activity and the ability to penetrate bacterial biofilms, limiting their efficacy against the treatment of BK. To remedy this, ZnFe layered double hydroxide (ZnFe-LDH) nanosheets are loaded with Cu single-atom nanozymes (Cu-SAzymes) and aminated dextran (Dex-NH), resulting in the formation of the nanozyme DT-ZnFe-LDH@Cu, which possesses peroxidase (POD)-, oxidase (OXD)-, and catalase (CAT)-like catalytic activities.

View Article and Find Full Text PDF

High defect concentrations at the interfaces are the basis of charge extraction losses and instability in perovskite solar cells. Surface engineering with organic cations is a common practice to solve this issue. However, the full implications of the counteranions of these cations for device functioning are often neglected.

View Article and Find Full Text PDF

In cancer research and personalized medicine, mesoporous silica nanoparticles (MSNs) have emerged as a significant breakthrough in both cancer treatment and diagnosis. MSNs offer targeted drug delivery, enhancing therapeutic effectiveness while minimizing adverse effects on healthy cells. Due to their unique characteristics, MSNs provide targeted drug delivery, maximizing therapeutic effectiveness with minimal adverse effects on healthy cells.

View Article and Find Full Text PDF

Ligands of CD6: roles in the pathogenesis and treatment of cancer.

Front Immunol

January 2025

Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.

Cluster of Differentiation 6 (CD6), an established marker of T cells, has multiple and complex functions in regulation of T cell activation and proliferation, and in adhesion of T cells to antigen-presenting cells and epithelial cells in various organs and tissues. Early studies on CD6 demonstrated its role in mediating cell-cell interactions through its first ligand to be identified, CD166/ALCAM. The observation of CD6-dependent functions of T cells that could not be explained by interactions with CD166/ALCAM led to discovery of a second ligand, CD318/CDCP1.

View Article and Find Full Text PDF

Introduction: Ocular pain is a common complaint to eye care providers, associated with a variety of ocular conditions, among which dry eye disease (DED) is affecting millions of people worldwide. Despite being highly prevalent, ocular pain is not managed adequately in the clinic.

Objectives: The aim of this study was to investigate the analgesic potential of neurokinin-1 receptor (NK1R) antagonism in DED.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!